Washington, DC 4/1/14; Minneapolis, MN 4/4/14; Minneapolis, MN 4/15/14—The R&D Systems subsidiary of Techne, now doing business as Bio-Techne, has agreed to acquire Shanghai PrimeGene Biotech (PrimeGene) for an undisclosed amount. PrimeGene develops, manufactures and distributes recombinant proteins for research and diagnostic applications, and had 2013 sales of $4 million. “The PrimeGene business expands our […]
Hercules, CA 4/10/14; Cambridge, MA 4/10/14—Bio-Rad Laboratories, a provider of products for clinical diagnostics and life science research, has acquired Cambridge, Massachusetts–based GnuBIO, for an undisclosed amount. GnuBIO is the developer of a low-cost, droplet-based, integrated sequencing system that delivers results in hours rather than days. The instrument handles target selection, amplification, sequencing and informatics […]
Washington, DC 3/18/14—Bio-Rad Laboratories reported in its annual 10K SEC filing for 2013 that it has identified a material weakness in its internal control over financial reporting. This follows the company’s identification of other material weaknesses in internal controls in 2011 and 2012 (see IBO 4/30/13). In its latest 10K filing, the company stated, “we […]
Bagneux, France 3/4/14; Paris, France 3/20/14—Genomic Vision, a developer of DNA molecular combing technology, has announced that it plans to list on the Euronext Paris stock exchange. The company’s technology provides a panoramic view of large regions of the genome, including detection of structural variations, and allows the direct visualization of genetic anomalies. The company […]
Paisley, UK 3/17/14—Thermo Fisher Scientific has acquired Prionics, an animal health diagnostics company, for an undisclosed amount. Headquartered in Zurich, Switzerland, Prionics’ product line includes more than 50 diagnostics test kits, accessories and biochemicals. Prionics will be part of Thermo’s Life Technologies brand. “Prionics adds a unique blend of expertise and diagnostic solutions to new […]
Cambridge, UK 3/24/14 Cambridge, UK 3/27/14—Gene editing technology firm Horizon Discovery has raised £68.6 million ($113.1 million = £0.61 = $1) in its IPO, resulting in gross proceeds of £40 million ($66 million), prior to listing its shares on the UK’s AIM stock exchange on March 27 (see IBO 2/28/14). The firm started trading at […]
Munich, Germany 2/28/14 — Attocube Systems, a provider of scanning probe microscopy systems and nanopositioning devices, has acquired a majority holding in Neaspec, a developer of scanning near field optical microscopes (SNOM). “Neaspec’s sophisticated products and their first-class technical know-how ideally complement our existing portfolio,” said attocube CEO Dr. Dirk Haft.
Miami, FL 3/4/14—Beckman Coulter Life Sciences has announced an agreement with Wyatt Technology for collaboration on products, applications and technical development for nanoparticle characterization. Beckman Coulter Life Sciences offers products for particle counting, particle characterization and cell viability measurement. Wyatt specializes in products for protein characterization, light scattering and biophysics. The codeveloped products will be […]
Rye Brook, NY 3/3/14—Xylem, whose Test business supplies analytical and process instrumentation, has named Patrick K. Decker president and CEO. Most recently, he was president and CEO of Harsco, a global industrial services company, and previously was president of Tyco Flow Control. He succeeds Steven R. Loranger, who remains a Board member. “The Board of […]
Begbroke, UK 3/4/14—Oxford Gene Technology (OGT) has acquired Cytocell, a UK-based provider of FISH (fluorescence in situ hybridization) probes for the detection of gene rearrangements related to inherited genetic disease and cancer. The purchase price was not disclosed. Cytocell sales grew 20% to £4.5 million ($7.0 million=£0.64 = $1) in the last financial year. “Cytocell […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
